Cargando…

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leber, Mathias Felix, Baertsch, Marc-Andrea, Anker, Sophie Caroline, Henkel, Luisa, Singh, Hans Martin, Bossow, Sascha, Engeland, Christine E., Barkley, Russell, Hoyler, Birgit, Albert, Jessica, Springfeld, Christoph, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026446/ https://www.ncbi.nlm.nih.gov/pubmed/29988512 http://dx.doi.org/10.1016/j.omto.2018.04.002

Ejemplares similares

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021)

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
por: Backhaus, Paul S., et al.
Publicado: (2019)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
por: Veinalde, Rūta, et al.
Publicado: (2021)

Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation
por: Busch, Elena, et al.
Publicado: (2020)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
por: Kontermann, Roland E., et al.
Publicado: (2021)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
por: Achard, Carole, et al.
Publicado: (2018)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021)

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2017)

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
por: Ungerechts, Guy, et al.
Publicado: (2010)

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
por: Hajda, Jacek, et al.
Publicado: (2017)

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
por: Kemler, Iris, et al.
Publicado: (2018)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
por: Loewe, Daniel, et al.
Publicado: (2022)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020)

Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
por: Li, H, et al.
Publicado: (2010)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Aeration and Shear Stress Are Critical Process Parameters for the Production of Oncolytic Measles Virus
por: Grein, Tanja A., et al.
Publicado: (2019)

Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
por: Xia, Mao, et al.
Publicado: (2019)

In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models
por: Jing, Yuqi, et al.
Publicado: (2014)

Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
por: Packiriswamy, Nandakumar, et al.
Publicado: (2020)

Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
por: Walle, Thomas, et al.
Publicado: (2022)

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
por: Walle, Thomas, et al.
Publicado: (2022)

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells
por: Angelova, Assia, et al.
Publicado: (2023)

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
por: Hudacek, Andrew W., et al.
Publicado: (2013)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
por: Iankov, Ianko D., et al.
Publicado: (2015)

Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
por: Musibay, Evidio Domingo, et al.
Publicado: (2014)

Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
por: Lal, Sangeet, et al.
Publicado: (2017)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
por: Hutzen, Brian, et al.
Publicado: (2012)

Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013)

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
por: Allen, Cory, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j0nik0sg94h1ge0cddjnutijpg